REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dermakare Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: Dermakare Pharmaceuticals Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dermakare Pharmaceuticals Private Limited is an unlisted company, incorporated on 12/02/2011. It has its registered office in the State of Uttar Pradesh, India. Company's corporate identification number (CIN) is U74900UP2011PTC043538 and registration number is 043538. The company is a trade company, it is engaged in wholesale trading.

Legal Address
F-390 Transport Nagar Kanpur Road
Lucknow; Uttar Pradesh; Postal Code: 226012

Contact Details: Purchase the Dermakare Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dermakare Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Dermakare Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Dermakare Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 12, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Dermakare Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.23%▲
Total operating revenue
11.23%▲
Operating profit (EBIT)
-36.06%▼
EBITDA
-10.9%▼
Net Profit (Loss) for the Period
-40%▼
Total assets
12.15%▲
Total equity
-0.56%▼
Operating Profit Margin (ROS)
-1.11%▼
Net Profit Margin
-0.89%▼
Return on Equity (ROE)
-2.12%▼
Debt to Equity Ratio
41.09%▲
Quick Ratio
0.52%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo